Clinical Trial Update: Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dexamethasone delivered via bullfrog catheter to reduce restenosis after angioplasty for chronic limb ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb Ischemia

Drugs mentioned

• DexaMethasone (DexaMethasone via Bullfrog device) (dexamethasone)

Snippet

Sponsor: Mercator MedSystems, Inc. | Conditions: Chronic Limb Ischemia | Phase 2 | Status: UNKNOWN